Elizabeth Irving and Hélène Kergoat receive funding to study Parkinson’s disease

Monday, July 16, 2012

Dr. Elizabeth Irving and Dr. Hélène Kergoat receive funding to study Convergence Insufficiency and Parkinson’s disease.

Their project has received 3 years of funding totaling $225,000 from the Canadian Institutes of Health Research (CIHR) and an additional $4,000 from the Canadian Optometric Education Trust Fund (COETF).

  Dr. Irving  from the Waterloo School of Optometry & Vision Science and Dr. Kergoat (the projects principal investigator) from the Montreal School of Optometry are collaborating to specifically look at “Improving vision-targeted health-related quality of life in Parkinson's disease: A feasibility study for orthoptic treatment of convergence insufficiency.” 

Dr. Irving has received her OD, MSc and PhD degrees from Waterloo and has worked at the School since 1985.   As a University Research Chair, she is an accomplished and recognized researcher in the area of eye development and adaptation.  Dr. Kergoat also has Masters and PhD degrees from the Waterloo School of Optometry & Vision Science.

  1. 2012 (2)